Trials / Conditions / CML, Refractory
CML, Refractory
3 registered clinical trials studyying CML, Refractory — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS NCT03884829 | Cyclacel Pharmaceuticals, Inc. | Phase 1 |
| Recruiting | A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Pre NCT03459534 | Il-Yang Pharm. Co., Ltd. | Phase 3 |
| Temporarily Not Available | Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who NCT07517315 | Sun Pharma Advanced Research Company Limited | — |